Neha Vapiwala

Prof. Neha Vapiwala


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 April 2021 in BMC Public Health
Verified
Journal Article
Open access
PDF file
NVNeha Vapiwala
Neha Vapiwala
DMDavid Miller
David Miller
BLBrenda Laventure
Brenda Laventure
KWKristina Woodhouse
Kristina Woodhouse
SKSheila Kelly
Sheila Kelly
KGKaren Glanz
Karen Glanz
Background: Health disparities in prostate cancer (PC) are thought to reflect the complex interplay of socioeconomics, environment and biology. The potential impact of beliefs and perceptions about PC among Black and Latino populations on clinical disparities are not well understood. This qualitative study was conducted to assess current prevalent and pervasive stigma, beliefs and perceptions regarding PC among Blacks and Latinos living in a large metropolitan area, thereby identifying potentially modifiable barriers to care. Methods: Qualitative data were collected through four separate focus groups of self-identified Black and Latino adult men and women living in Philadelphia to better understand their perceptions of PC diagnosis, screening and treatment. Each focus group was single-sex and conducted by racial/ethnic group in order to assess possible differences in beliefs about PC based on gender and racial/ethnic affiliation. Audio recordings were transcribed verbatim by trained research assistants and qualitative data analysis was conducted using modified grounded theory. Results: There were a total of 34 participants: 19 Hispanics/Latinos and 15 Blacks, with equal numbers of men and women (n=17). Median age was 57 years (range: 18 to 85 years). Dominant themes that emerged with respect to PC diagnosis included the stigma surrounding this condition and the perceived role of an “unhealthy lifestyle” and certain sexual behaviors as risk factors for PC development. While the majority of participants acknowledged the importance of PC screening and early detection, discussion centered around the barriers to both the interest in seeking medical care and the likelihood of securing it. These barriers included misunderstanding of PC etiology, distrust of the medical profession, and financial/access limitations. Men expressed substantial confusion about PC screening guidelines. In the Black female group, the role of faith and religion in the course of disease was a major theme. Both Black and Latina females discussed the role of fear and avoidance around PC screening and treatment, as well as the prevalence of misinformation about PC in their familial and social communities. Conclusion: Black and Latino focus groups revealed the existence of cultural beliefs, misunderstandings and fears pertaining to PC which could influence health-related behaviors. Some themes were common across groups; others suggested racial and gender predilections. Future targeted efforts focused on directly addressing prevalent misperceptions among underserved communities in urban settings could help to improve health literacy and equity in PC outcomes in these populations.

15 August 2024 in European Journal of Nuclear Medicine and Molecular Imaging
Verified
Journal Article
Open access
PDF file
Shadi A. EsfahaniShadi A. Esfahani
Shadi A. Esfahani
MMMichael J. Morris
Michael J. Morris
OSOliver Sartor
Oliver Sartor
MFMark Frydenberg
Mark Frydenberg
Stefano FantiStefano Fanti
Stefano Fanti
NVNeha Vapiwala
Neha Vapiwala
Purpose: Accurate diagnosis and staging of prostate cancer are crucial to improving patient care. Prostate-specific membrane antigen (PSMA)-targeted positron emission tomography with computed tomography (PET/CT) imaging has demonstrated superiority for initial staging and restaging in patients with prostate cancer. Referring physicians and PET/CT readers must agree on a consistent communication method and application of information derived from this imaging modality. While several guidelines have been published, a single PSMA PET/CT reporting template has yet to be widely adopted. Based on the consensus from community and academic physicians, we developed a standardized PSMA PET/CT reporting template for radiologists and nuclear medicine physicians to report and relay key imaging findings to referring physicians. The aim was to improve the quality, clarity, and utility of imaging results reporting to facilitate patient management decisions. Methods: Based on community and expert consensus, we developed a standardized PSMA PET/CT reporting template to deliver key imaging findings to referring clinicians. Results: Core category components proposed include a summary of any prior treatment history; presence, location, and degree of PSMA radiopharmaceutical uptake in primary and/or metastatic tumor(s), lesions with no uptake, and incidentally found lesions with positive uptake on PET/CT. Conclusions: This article provides recommendations on best practices for standardized reporting of PSMA PET/CT imaging. The generated reporting template is a proposed supplement designed to educate and improve data communication between imaging experts and referring physicians.

2 April 2023 in Cancers
Verified
Journal Article
Open access
PDF file
SCSumedha Chhatre
Sumedha Chhatre
JGJoseph J. Gallo
Joseph J. Gallo
TGThomas Guzzo
Thomas Guzzo
KMKnashawn H. Morales
Knashawn H. Morales
DNDiane K. K. Newman
Diane K. K. Newman
RJRavishankar Jayadevappa
Ravishankar Jayadevappa
Background: While psychological difficulties, such as depression, among prostate cancer patients are known, their longitudinal burden remains understudied. We assessed the burden of depression across low-, intermediate- and high-risk prostate cancer groups, and the association between regret and long-term depression. Methods: Secondary analysis of data from a multi-centered randomized controlled study among localized prostate cancer patients was carried out. Assessments were performed at baseline, and at 3-, 6-, 12- and 24-month follow-up. Depression was assessed using the Center for Epidemiologic Studies Depression (CES-D) scale. A CES-D score ≥ 16 indicates high depression. Regret was measured using the regret scale of the Memorial Anxiety Scale for Prostate Cancer (MAX-PC). The proportion of patients with high depression was compared over time, for each risk category. Logistic regression was used to assess the association between regret, and long-term depression after adjusting for age, race, insurance, smoking status, marital status, income, education, employment, treatment, number of people in the household and study site. Results: The study had 743 localized prostate cancer patients. Median depression scores at 6, 12 and 24 months were significantly larger than the baseline median score, overall and for the three prostate cancer risk groups. The proportion of participants with high depression increased over time for all risk groups. Higher regret at 24-month follow-up was significantly associated with high depression at 24-month follow-up, after adjusting for covariates. Conclusions: A substantial proportion of localized prostate cancer patients continued to experience long-term depression. Patient-centered survivorship care strategies can help reduce depression and regret, and improve outcomes in prostate cancer care.

27 October 2021 in Academic Medicine
Verified
Journal Article
Closed access
CWCheyenne Williams
Cheyenne Williams
MPMichael A. Perez
Michael A. Perez
NVNeha Vapiwala
Neha Vapiwala
JSJudy A. Shea
Judy A. Shea

5 August 2020 in Academic Medicine
Verified
Journal Article
Closed access
MPMichael Perez
Michael Perez
CWCheyenne Williams
Cheyenne Williams
NVNeha Vapiwala
Neha Vapiwala
An abstract is unavailable. This article is available as a PDF only.

22 July 2023 in Physics and Imaging in Radiation Oncology
Verified
Journal Article
Open access
SFSen-Quan Feng
Sen-Quan Feng
CBCharlotte L Brouwer
Charlotte L Brouwer
Erik W. KorevaarErik W. Korevaar
Erik W. Korevaar
NVNeha Vapiwala
Neha Vapiwala
KWKen Kang-Hsin Wang
Ken Kang-Hsin Wang
SAShafak S. Aluwini
Shafak S. Aluwini
• Synthetic computed tomography images were used to simulate real-time prostate position • A 4D simulation method of intra-fractional prostate motion was developed • Prostate motion had minimal dose impact to robustly optimized proton therapy